Short answer
CG Oncology, Inc. (CGON) filed an 8-K current report with the SEC on February 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). CGON reported full-year and Q4 2025 financial results via press release dated February 27, 2026.
CG Oncology, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- CGON reported full-year and Q4 2025 financial results via press release dated February 27, 2026
- Actual figures in Exhibit 99.1: filing itself contains no financial data; refer to attached press release for revenue, cash, and expense details
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CG Oncology, Inc. 8-K filings
Get the next CGON 8-K as it lands
Follow CGON for push alerts, or ask the research agent what this filing means.